- Home
- VATE vs ANVS Comparison
VATE vs ANVS Comparison
Compare VATE & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- ANVS
- Stock Information
- Founded
- VATE 1994
- ANVS 2008
- Country
- VATE United States
- ANVS United States
- Employees
- VATE N/A
- ANVS N/A
- Industry
- VATE Metal Fabrications
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- ANVS Health Care
- Exchange
- VATE Nasdaq
- ANVS Nasdaq
- Market Cap
- VATE 63.2M
- ANVS 55.5M
- IPO Year
- VATE 1996
- ANVS 2020
- Fundamental
- Price
- VATE $4.69
- ANVS $2.74
- Analyst Decision
- VATE
- ANVS Strong Buy
- Analyst Count
- VATE 0
- ANVS 4
- Target Price
- VATE N/A
- ANVS $18.00
- AVG Volume (30 Days)
- VATE 29.1K
- ANVS 277.6K
- Earning Date
- VATE 08-05-2025
- ANVS 08-12-2025
- Dividend Yield
- VATE N/A
- ANVS N/A
- EPS Growth
- VATE N/A
- ANVS N/A
- EPS
- VATE N/A
- ANVS N/A
- Revenue
- VATE $995,000,000.00
- ANVS N/A
- Revenue This Year
- VATE N/A
- ANVS N/A
- Revenue Next Year
- VATE N/A
- ANVS N/A
- P/E Ratio
- VATE N/A
- ANVS N/A
- Revenue Growth
- VATE N/A
- ANVS N/A
- 52 Week Low
- VATE $3.25
- ANVS $1.11
- 52 Week High
- VATE $13.79
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- VATE 41.27
- ANVS 52.55
- Support Level
- VATE $4.40
- ANVS $2.58
- Resistance Level
- VATE $5.21
- ANVS $2.94
- Average True Range (ATR)
- VATE 0.57
- ANVS 0.21
- MACD
- VATE -0.09
- ANVS -0.00
- Stochastic Oscillator
- VATE 11.89
- ANVS 64.41
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.